Title : Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.

Pub. Date : 2018 Nov

PMID : 30031824






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-kappaB, and the induction of autophagy. daphnetin nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
2 Moreover, Daph treatment effectively inhibited LPS/GalN-induced nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3), mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappaB) signaling pathway activation, and significantly induced autophagy activation by enhancing the level of pro-autophagy proteins expression. daphnetin nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
3 Moreover, Daph treatment effectively inhibited LPS/GalN-induced nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3), mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappaB) signaling pathway activation, and significantly induced autophagy activation by enhancing the level of pro-autophagy proteins expression. daphnetin nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
4 Taken together, these findings suggested that Daph plays a pivotal role in liver protection by suppressing inflammatory responses which may be closely associated with the inhibition of NLRP3 inflammasome, MAPK and NF-kappaB activation, as well as the induction of autophagy. daphnetin nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus